Semax | Nootropic Research Peptide
AUD $120
For laboratory research use only. Not for human use.
Research-grade Semax — a synthetic heptapeptide derived from ACTH 4-10. Studied in preclinical models for BDNF expression, cognitive function, and neuroprotection. Third-party HPLC tested to ≥98% purity. For laboratory research use only.
Supply Specifications
| Peptide | Semax (Met-Glu-His-Phe-Pro-Gly-Pro) |
| Format | Lyophilised powder |
| Purity | ≥98% by HPLC |
| Testing | Third-party HPLC + Mass Spec |
| Storage | -20°C lyophilised; 2–8°C reconstituted |
| Use | Laboratory research use only |
| Price | AUD $120 |
Research Summary
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH 4-10 fragment. It has been studied in preclinical models for its apparent effects on BDNF (brain-derived neurotrophic factor) expression, cognitive function, and neuroprotection.
Semax is used in clinical practice in Russia and Ukraine for neurological conditions including ischaemic stroke and cognitive impairment. It is not TGA-approved in Australia and is available for laboratory research use only.
Related Research
Disclaimer: All products supplied by PeptideIQ are for laboratory research use only. They are not approved for human use, consumption, or therapeutic application. PeptideIQ complies with all applicable Australian regulations including the Therapeutic Goods Act 1989.